CVE-2026-17583
File-tampering in Thermo Fisher genetic analyzer outputs can falsify DNA results.
Is CVE-2026-17583 being exploited?
Not confirmed. CVE-2026-17583 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.21% probability of exploitation in the next 30 days.
How severe is CVE-2026-17583?
CVE-2026-17583 is rated High with a CVSS score of 8.3. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-17583?
Yes. A fix has been recorded for CVE-2026-17583. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-17583 affect?
CVE-2026-17583 affects Thermo Fisher Applied Biosystems Genetic Analyzers (.fsa/.hid outputs). Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-17583?
Isolate affected devices, validate past and new outputs, enforce file integrity/digital signatures, contact vendor.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Modify .fsa/.hid output files to falsify DNA results, enabling misdiagnosis, treatment errors, research corruption, or forensic evidence tampering.
Immediate action required
- affected<= 2.0
- affected<= 3.1
- affected<= 4.1
- affected<= 4.0.2
- affected<= 5.0.2
- affected<= 1.7.3
- affected<= 1.2.0
- affected<= 1.2.5
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.